Altogether, our data suggest that PSMD1 and PSMD3 stabilize NF-κB from degradation in CML, and that STAT3 perpetuates this signal in scenarios of TKI resistance. The gene discussed is STAT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.